2023-04-012024-03-312024-03-31false13964988Extracellular Ltd2024-08-2371121iso4217:GBPxbrli:pure139649882023-04-01139649882024-03-31139649882023-04-012024-03-31139649882022-03-09139649882023-03-31139649882022-03-092023-03-3113964988bus:SmallEntities2023-04-012024-03-3113964988bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3113964988bus:AbridgedAccounts2023-04-012024-03-3113964988bus:PrivateLimitedCompanyLtd2023-04-012024-03-3113964988core:WithinOneYear2024-03-3113964988core:AfterOneYear2024-03-3113964988core:WithinOneYear2023-03-3113964988core:AfterOneYear2023-03-3113964988core:ShareCapital2024-03-3113964988core:SharePremium2024-03-3113964988core:RevaluationReserve2024-03-3113964988core:OtherReservesSubtotal2024-03-3113964988core:RetainedEarningsAccumulatedLosses2024-03-3113964988core:ShareCapital2023-03-3113964988core:SharePremium2023-03-3113964988core:RevaluationReserve2023-03-3113964988core:OtherReservesSubtotal2023-03-3113964988core:RetainedEarningsAccumulatedLosses2023-03-3113964988core:LandBuildings2024-03-3113964988core:PlantMachinery2024-03-3113964988core:Vehicles2024-03-3113964988core:FurnitureFittings2024-03-3113964988core:OfficeEquipment2024-03-3113964988core:NetGoodwill2024-03-3113964988core:IntangibleAssetsOtherThanGoodwill2024-03-3113964988core:ListedExchangeTraded2024-03-3113964988core:UnlistedNon-exchangeTraded2024-03-3113964988core:LandBuildings2023-03-3113964988core:PlantMachinery2023-03-3113964988core:Vehicles2023-03-3113964988core:FurnitureFittings2023-03-3113964988core:OfficeEquipment2023-03-3113964988core:NetGoodwill2023-03-3113964988core:IntangibleAssetsOtherThanGoodwill2023-03-3113964988core:ListedExchangeTraded2023-03-3113964988core:UnlistedNon-exchangeTraded2023-03-3113964988core:LandBuildings2023-04-012024-03-3113964988core:PlantMachinery2023-04-012024-03-3113964988core:Vehicles2023-04-012024-03-3113964988core:FurnitureFittings2023-04-012024-03-3113964988core:OfficeEquipment2023-04-012024-03-3113964988core:NetGoodwill2023-04-012024-03-3113964988core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113964988core:ListedExchangeTraded2023-04-012024-03-3113964988core:UnlistedNon-exchangeTraded2023-04-012024-03-3113964988core:MoreThanFiveYears2023-04-012024-03-3113964988core:Non-currentFinancialInstruments2024-03-3113964988core:Non-currentFinancialInstruments2023-03-3113964988dpl:CostSales2023-04-012024-03-3113964988dpl:DistributionCosts2023-04-012024-03-3113964988core:LandBuildings2023-04-012024-03-3113964988core:PlantMachinery2023-04-012024-03-3113964988core:Vehicles2023-04-012024-03-3113964988core:FurnitureFittings2023-04-012024-03-3113964988core:OfficeEquipment2023-04-012024-03-3113964988dpl:AdministrativeExpenses2023-04-012024-03-3113964988core:NetGoodwill2023-04-012024-03-3113964988core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113964988dpl:GroupUndertakings2023-04-012024-03-3113964988dpl:ParticipatingInterests2023-04-012024-03-3113964988dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113964988core:ListedExchangeTraded2023-04-012024-03-3113964988dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113964988core:UnlistedNon-exchangeTraded2023-04-012024-03-3113964988dpl:CostSales2022-03-092023-03-3113964988dpl:DistributionCosts2022-03-092023-03-3113964988core:LandBuildings2022-03-092023-03-3113964988core:PlantMachinery2022-03-092023-03-3113964988core:Vehicles2022-03-092023-03-3113964988core:FurnitureFittings2022-03-092023-03-3113964988core:OfficeEquipment2022-03-092023-03-3113964988dpl:AdministrativeExpenses2022-03-092023-03-3113964988core:NetGoodwill2022-03-092023-03-3113964988core:IntangibleAssetsOtherThanGoodwill2022-03-092023-03-3113964988dpl:GroupUndertakings2022-03-092023-03-3113964988dpl:ParticipatingInterests2022-03-092023-03-3113964988dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-092023-03-3113964988core:ListedExchangeTraded2022-03-092023-03-3113964988dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-092023-03-3113964988core:UnlistedNon-exchangeTraded2022-03-092023-03-3113964988core:NetGoodwill2024-03-3113964988core:IntangibleAssetsOtherThanGoodwill2024-03-3113964988core:LandBuildings2024-03-3113964988core:PlantMachinery2024-03-3113964988core:Vehicles2024-03-3113964988core:FurnitureFittings2024-03-3113964988core:OfficeEquipment2024-03-3113964988core:AfterOneYear2024-03-3113964988core:WithinOneYear2024-03-3113964988core:ListedExchangeTraded2024-03-3113964988core:UnlistedNon-exchangeTraded2024-03-3113964988core:ShareCapital2024-03-3113964988core:SharePremium2024-03-3113964988core:RevaluationReserve2024-03-3113964988core:OtherReservesSubtotal2024-03-3113964988core:RetainedEarningsAccumulatedLosses2024-03-3113964988core:NetGoodwill2023-03-3113964988core:IntangibleAssetsOtherThanGoodwill2023-03-3113964988core:LandBuildings2023-03-3113964988core:PlantMachinery2023-03-3113964988core:Vehicles2023-03-3113964988core:FurnitureFittings2023-03-3113964988core:OfficeEquipment2023-03-3113964988core:AfterOneYear2023-03-3113964988core:WithinOneYear2023-03-3113964988core:ListedExchangeTraded2023-03-3113964988core:UnlistedNon-exchangeTraded2023-03-3113964988core:ShareCapital2023-03-3113964988core:SharePremium2023-03-3113964988core:RevaluationReserve2023-03-3113964988core:OtherReservesSubtotal2023-03-3113964988core:RetainedEarningsAccumulatedLosses2023-03-3113964988core:NetGoodwill2022-03-0913964988core:IntangibleAssetsOtherThanGoodwill2022-03-0913964988core:LandBuildings2022-03-0913964988core:PlantMachinery2022-03-0913964988core:Vehicles2022-03-0913964988core:FurnitureFittings2022-03-0913964988core:OfficeEquipment2022-03-0913964988core:AfterOneYear2022-03-0913964988core:WithinOneYear2022-03-0913964988core:ListedExchangeTraded2022-03-0913964988core:UnlistedNon-exchangeTraded2022-03-0913964988core:ShareCapital2022-03-0913964988core:SharePremium2022-03-0913964988core:RevaluationReserve2022-03-0913964988core:OtherReservesSubtotal2022-03-0913964988core:RetainedEarningsAccumulatedLosses2022-03-0913964988core:AfterOneYear2023-04-012024-03-3113964988core:WithinOneYear2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3113964988core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113964988core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113964988core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113964988core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113964988core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113964988core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113964988core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113964988core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3113964988core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3113964988core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3113964988core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3113964988core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3113964988core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3113964988core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3113964988core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3113964988bus:Director12023-04-012024-03-3113964988bus:Director22023-04-012024-03-31

Extracellular Ltd

Registered Number
13964988
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

Extracellular Ltd
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

Fletcher, Catherine Jane
Milligan, William Robert

Registered Address

Science Creates Old Market
Midland Road
Bristol
BS2 0JZ

Registered Number

13964988 (England and Wales)
Extracellular Ltd
Statement of Financial Position
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets37,5478,053
Tangible assets4460,690362,012
468,237370,065
Current assets
Debtors373,583128,490
Cash at bank and on hand166,798238,717
540,381367,207
Creditors amounts falling due within one year(167,467)(166,959)
Net current assets (liabilities)372,914200,248
Total assets less current liabilities841,151570,313
Creditors amounts falling due after one year(670,863)(219,825)
Net assets170,288350,488
Capital and reserves
Called up share capital11
Share premium108,815-
Profit and loss account61,472350,487
Shareholders' funds170,288350,488
The financial statements were approved and authorised for issue by the Board of Directors on 23 August 2024, and are signed on its behalf by:
Milligan, William Robert
Director
Registered Company No. 13964988
Extracellular Ltd
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Separately acquired patents, trademarks and licences are shown at historical cost. Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date. Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses. Amortisation is provided on patents starting on the date on which the patents are granted so as to write off the cost, less any estimated residual value, over their useful life as follows: Straight line over 20 years
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20242023
Average number of employees during the year1111
3.Intangible assets

Total

£
Cost or valuation
At 01 April 238,180
At 31 March 248,180
Amortisation and impairment
At 01 April 23127
Charge for year506
At 31 March 24633
Net book value
At 31 March 247,547
At 31 March 238,053
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 23414,684
Additions226,425
At 31 March 24641,109
Depreciation and impairment
At 01 April 2352,672
Charge for year132,544
Other adjustments(4,797)
At 31 March 24180,419
Net book value
At 31 March 24460,690
At 31 March 23362,012